Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. was founded in 2023, and has been adhering to the developing concept of the parent company, NGP, which has always stood strong in the face of inheriting and popularizing the millennial-long TCM culture with modern techniques.
We have served many regions around the world, including traditional Chinese medicine clinics, herbal extract wholesalers, medical institutions, and clinics. "We are committed to empowering global pharmacies through an efficient B2B supply chain to safeguard health."
The global herbal medicine market has witnessed an unprecedented surge, with Moxibustion Herb products and TCM granules leading the transition from traditional raw formats to refined, industrial-grade extracts. In North America and Europe, the demand for standardized Moxibustion Herb has shifted from ethnic niches to mainstream wellness and pharmaceutical sectors. As medical professionals seek alternative therapies for chronic pain and metabolic health, the commercial value of highly concentrated, water-soluble granules has increased significantly.
Current industrial trends indicate that the "clean-label" movement is impacting the TCM industry. Buyers now prioritize purity, traceability, and the absence of heavy metals or sulfur-processed residues. This shift has positioned leading Chinese manufacturers at the forefront of the global supply chain, utilizing advanced spray-drying and vacuum-concentration technologies to meet international pharmacopeia standards.
The future of TCM granules lies in the integration of AI-driven quality control and intelligent fingerprinting technology. Modern manufacturers are now able to provide "Chemical Fingerprints" for every batch of Moxibustion Herb, ensuring that the active therapeutic compounds remain consistent. This level of precision is crucial for large-scale clinical applications and pharmaceutical procurement.
Global procurement needs are evolving toward "ready-to-use" formats. Formula Herb Granules that require no decoction are becoming the gold standard for hospital dispensaries and retail pharmacies. We are seeing a 25% annual growth in the adoption of TCM granules over raw herbs in Western markets due to their convenience and dosage accuracy.
As one of the only six pilot manufacturers approved by the Chinese government for TCM granules, Sichuan Neo-Green Pharmaceutical (NGP) offers unparalleled advantages:
Our US subsidiary, Neo-Green Herbs INC, provides localized support, ensuring that our B2B partners receive rapid response times and expert consultation in their own time zone.
Founded in 2009, Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd (NGP) is a comprehensive TCM enterprise integrating research and development, production and operation, especially in the field of TCM granules, which enjoys a high reputation. As a “National Enterprise Technology Center”, “High-tech Enterprise” and “National Key Leading Enterprise in Agricultural Industrialization”, NGP is not only one of the six pilot manufacturers approved by China for the formulation and production of TCM granules, but also the only TCM granule enterprise in the southwestern region of China.
Whether you are a wholesaler in Europe or a clinic owner in North America, our Moxibustion Herb and TCM granule solutions are designed to fit seamlessly into diverse medical environments.
Eliminate the need for traditional boiling. Our granules offer instant solubility, improving patient compliance and clinical efficiency.
Integrate our high-purity extracts into your own formula capsules, powders, or wellness teas with full COA documentation.
Access standardized chemical profiles of traditional herbs for scientific study and pharmacological trials.
Neo-Green Herbs